Phase III Randomized Controlled Study Comparing Survival

Project: Research project

Project Details

Description

Phase III Randomized Controlled Study Comparing Survival of Patients w/Unresectable Hepatocellular Carcinoma (HCC) Treated w/Thymitaq to Patients Treated with Doxorubicin
StatusFinished
Effective start/end date8/24/018/23/09

Funding

  • EXIMIAS PHARM CORP

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.